Phase II Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) in Surgically Operable Stage I Non-Small Cell Lung Cancer (STARS)

被引：0
|
作者：
Chang, Joe Y. [1 ]
Mehran, Reza [2 ]
Balter, Peter [1 ]
Mcrae, Stephen [3 ]
Feng, Lei [4 ]
Berry, Donald [4 ]
Komaki, Ritsuko U. [1 ]
Roth, Jack [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Thorac Surg, Houston, AL USA
[3] Univ Texas MD Anderson Canc Ctr, Radiol, Houston, AL USA
[4] Univ Texas MD Anderson Canc Ctr, Biostat, Houston, AL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
operable Stage I lung cancer; stereotactic radiotherapy; SBRT; SABR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.02-032
引用
收藏
页码：S563 / S563
页数：1
相关论文
共 50 条
  • [31] Lobectomy versus Stereotactic Ablative Radiotherapy (SABR) for Stage I Non Small Cell Lung Cancer (NSCLC) in 182 Patients
    Scotti, Vieri
    Simontacchi, Gabriele
    Furfaro, Ilaria Francesca
    Scartoni, Daniele
    Gonfiotti, Alessandro
    Viggiano, Domenico
    Cardillo, Carla De Luca
    Ferrari, Katia
    Agresti, Benedetta
    Zei, Giacomo
    Perna, Marco
    Bastiani, Paolo
    Bruni, Alessio
    Voltolini, Luca
    Livi, Lorenzo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S675 - S675
  • [32] Immune Activation in Early Stage Non-Small Cell Lung Cancer (NSCLC) following Stereotactic Ablative Radiotherapy (SABR) and Surgery
    Aerts, Joachim G.
    De Goeje, Pauline
    Schram, Merel
    Bezemer, Koen
    Kaijen-Lambers, Margaretha
    Hegmans, Joost
    De langen, Joop
    Maat, Alexander
    Nuyttens, Joost
    Hendriks, Rudi
    Smit, Egbert
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S326 - S326
  • [33] A Phase I Trial of an Immune Checkpoint Inhibitor Plus Stereotactic Ablative Radiotherapy in Patients with Early Stage Non-Small Cell Lung Cancer
    Daly, M.
    Monjazeb, A.
    Mirhadi, A.
    Eastham, D.
    Lara, F.
    Riess, J.
    Wiegner, E.
    Kelly, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S254 - S254
  • [34] A PHASE II TRIAL MEASURING THE INTEGRATION OF STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) PLUS SURGERY IN OPERABLE PATIENTS WITH EARLY NON-SMALL CELL LUNG CANCER (MISSILE-NSCLC): INTERIM SAFETY RESULTS
    Palma, David
    Kwan, Keith
    Gaede, Stewart
    Landis, Mark
    Malthaner, Richard
    Fortin, Dalilah
    Louie, Alexander
    Frechette, Eric
    Rodrigues, George
    Yaremko, Brian
    Yu, Edward
    Dar, Rashid
    Lee, Ting-Yim
    Gratton, Albert
    Ward, Aaron
    Inculet, Richard
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S58 - S58
  • [35] Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
    Chang, Joe Y.
    Liu, Hui
    Balter, Peter
    Komaki, Ritsuko
    Liao, Zhongxing
    Welsh, James
    Mehran, Reza J.
    Roth, Jack A.
    Swisher, Stephen G.
    RADIATION ONCOLOGY, 2012, 7
  • [36] Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
    Joe Y Chang
    Hui Liu
    Peter Balter
    Ritsuko Komaki
    Zhongxing Liao
    James Welsh
    Reza J Mehran
    Jack A Roth
    Stephen G Swisher
    Radiation Oncology, 7
  • [37] Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer
    de Ruiter, Julianne Cynthia
    van Diessen, Judi Nani Annet
    Smit, Egbert Frederik
    van der Noort, Vincent
    Damhuis, Ronald Alphons Maria
    Hartemink, Koen Johan
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (03)
  • [38] Long-term outcomes of Stereotactic Ablative Radiotherapy for stage I non-small cell lung cancer
    Lee, S.
    Song, S. Y.
    Kim, S. S.
    Lee, S. W.
    Ahn, S. D.
    Yoon, S. M.
    Kim, Y. S.
    Park, J. H.
    Kim, J. H.
    Choi, E. K.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S655 - S655
  • [39] Stereotactic ablative radiotherapy versus lobectomy for stage I non-small cell lung cancer: A systematic review
    Wang, Siwei
    Wang, Xiaoxiao
    Zhou, Qing
    Xu, Youtao
    Xia, Wenjia
    Xu, Weizhang
    Ma, ZhiFei
    Qiu, Mantang
    You, Ran
    Xu, Lin
    Yin, Rong
    THORACIC CANCER, 2018, 9 (03) : 337 - 347
  • [40] Feasibility of Stereotactic Ablative Radiotherapy (SABR) for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)
    Woodford, Katrina
    Panettieri, Vanessa
    Trieumy Tran Le
    Senthi, Sashendra
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1467 - S1468
12345